Anika Therapeutics vs Owlet
Anika Therapeutics and Owlet are similar in size: $113m and $106m of revenue in their latest fiscal years. Owlet grew faster (37.1% against -5.9%). Anika Therapeutics kept more of each dollar of sales as profit: a net margin of -9.6% against -36.6%.
| Latest fiscal year | Anika TherapeuticsANIK, 2025 | OwletOWLT, 2025 |
|---|---|---|
| Revenue | $113m | $106m |
| Revenue growth | -5.9% | 37.1% |
| Net income | −$10.9m | −$38.8m |
| Operating margin | -9.8% | — |
| Net margin | -9.6% | -36.6% |
| Return on equity | -7.3% | — |
| Free cash flow | $4.4m | −$11.1m |
| Cash | $57.5m | $35.5m |
| Total debt | $0 | $20.0m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $9.5m | — |
| Employees | 235 | 108 |
| Market value | $261m | $122m |
| Price vs our value range | — | — |
| Moat score | 53 (Moderate) | 25 (Weak) |
| Insider trades, 12 months | 4 buys, 0 sales | 0 buys, 6 sales |